Green Tea confers Protection on the Retina in MPTP Mice Model of Parkinson’s Disease

References (52)

1. 1 MOLECULAR PATHOPHYSIOLOGY OF PARKINSON'S DISEASE [DOI]
2. 2 Epidemiology and etiology of Parkinson’s disease: a review of the evidence [DOI]
3. 3 Hallucinations in Parkinson's disease: Prevalence, phenomenology and risk factors [DOI]
4. 4 A meta‐analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease [DOI]
5. 5 Predictors of Nursing Home Placement in Parkinson's Disease: A Population‐Based, Prospective Study [DOI]
6. 6 The cognitive ability of an incident cohort of Parkinson’s patients in the UK. The CamPaIGN study [DOI]
7. 7 The Major Green Tea Polyphenol, (-)-Epigallocatechin-3-Gallate, Inhibits Obesity, Metabolic Syndrome, and Fatty Liver Disease in High-Fat–Fed Mice [DOI]
8. 8 Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; Study using nonmotor symptoms questionnaire in 545 patients [DOI]
9. 9 Beneficial effects of tea catechins on diet-induced obesity: stimulation of lipid catabolism in the liver [DOI]
10. 10 Mental symptoms in Parkinson's disease are important contributors to caregiver distress [DOI]
11. 11 Epigallocatechin gallate attenuates diet-induced obesity in mice by decreasing energy absorption and increasing fat oxidation [DOI]
12. 12 The retina in Parkinson's disease [DOI]
13. 13 Parkinson's Disease Risks Associated with Cigarette Smoking, Alcohol Consumption, and Caffeine Intake [DOI]
14. 14 l-Theanine reduces psychological and physiological stress responses [DOI]
15. 15 Prospective study of hallucinations and delusions in Parkinson's disease [DOI]
16. 16 Dynamic Equilibrium of Neurotransmitter Transporters: Not Just for Reuptake Anymore [DOI]
17. 17 Mortality and hallucinations in nursing home patients with advanced Parkinson's disease [DOI]
18. 18 Memory and executive function impairment predict dementia in Parkinson's disease [DOI]
19. 19 Coffee and tea consumption and the risk of Parkinson's disease [DOI]
20. 20 Mitochondrial Dysfunction and Glutamate Excitotoxicity Studied in Primary Neuronal Cultures [DOI]
21. 21 Calcium, Bioenergetics, and Neuronal Vulnerability in Parkinson's Disease [DOI]
22. 22 Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease [DOI]
23. 23 Protective Effects of Green Tea Polyphenols in the 6-OHDA Rat Model of Parkinson’s Disease Through Inhibition of ROS-NO Pathway [DOI]
24. 24 Differential Effects of Black versus Green Tea on Risk of Parkinson's Disease in the Singapore Chinese Health Study [DOI]
25. 25 Genetic and environmental risk factors for Parkinson's disease in a Chinese population [DOI]
26. 26 The Malignant Course of “Benign Hallucinations” in Parkinson Disease [DOI]
27. 27 Assessing the effects of caffeine and theanine on the maintenance of vigilance during a sustained attention task [DOI]
28. 28 Depression and Parkinson?s disease [DOI]
29. 29 Effect of Naturally Occurring Flavonoids on Lipid Peroxidation and Membrane Permeability Transition in Mitochondria [DOI]
30. 30 Phenolic antioxidants attenuate neuronal cell death following uptake of oxidized low-density lipoprotein [DOI]
31. 31 Mitochondria and neuronal glutamate excitotoxicity [DOI]
32. 32 Sustained elevation of extracellular dopamine causes motor dysfunction and selective degeneration of striatal GABAergic neurons [DOI]
33. 33 Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson’s disease [DOI]
34. 34 Cognitive profiles of individual patients with Parkinson's disease and dementia: Comparison with dementia with lewy bodies and Alzheimer's disease [DOI]
35. 35 Smoking and tea consumption delay onset of Parkinson's disease [DOI]
36. 36 Ocular Motility in Parkinson's Disease [DOI]
37. 37 Autonomic dysfunction in 3414 Parkinson's disease patients enrolled in the German Network on Parkinson's disease (KNP e.V.): the effect of ageing [DOI]
38. 38 Epidemiology of Parkinson's disease [DOI]
39. 39 Sleep disturbances and excessive daytime sleepiness in Parkinson disease: an overview [DOI]
40. 40 Parkinson's Disease and Tea: A Quantitative Review [DOI]
41. 41 Visual evoked potentials in parkinsonism and dopamine blockade reveal a stimulus-dependent dopamine function in humans. [DOI]
42. 42 Theanine-induced Reduction of Brain Serotonin Concentration in Rats [DOI]
43. 43 Clinical phenotype of subjects with Parkinson's disease and orthostatic hypotension: Autonomic symptom and demographic comparison [DOI]
44. 44 Ophthalmologic features of Parkinson's disease [DOI]
45. 45 Visual hallucinations in Parkinson’s disease: a review and phenomenological survey [DOI]
46. 46 Long-term clinical evaluation in patients with Parkinson's disease and early autonomic involvement [DOI]
47. 47 Depression in Patients with Parkinson??s Disease [DOI]
48. 48 Ethical guidelines for investigations of experimental pain in conscious animals [DOI]
49. 49 Book Review: GABA and Glutamate in the Human Brain [DOI]
50. 50 CARLETON'S HISTOLOGICAL TECHNIQUE [DOI]
51. 51 Flavonoid Antioxidants [DOI]
52. 52 Studies on Experimental Models [DOI]

Cited by 0

No indexed citations yet.

Related research

• Virtual Reality–enhanced Rhythmic Auditory Cueing Versus Conventional Physiotherapy for Balance and Gait in Parkinson’s Disease: A Randomized Trial — shares topic coverage
• Virtual Reality-Based Interventions for Upper Limb Rehabilitation in Parkinson’s Disease: A Scoping Review and Critical Evidence Synthesis — shares topic coverage
• TrkA Pathway(s) are Involves in the Regulation of TRPM2 and TRPM7 Expression in the Substantia Nigra of the Parkinson’s Disease Rat Model Induced by 6-Hydroxydopamine — shares topic coverage
• Ergot Alkaloids: A Review on Therapeutic Applications — shares topic coverage
• ABO & Rh (D) Phenotypes and Alleles in the Patients with Parkinson’s Disease among the North Indian Population — shares topic coverage